Sex differences in discriminative stimulus effects of morphine in the rat

Behavioural Pharmacology

Volumn 7, Issue 8, 1996, Pages 764-778

  Craft, R M ^a   Kalivas, P W ^a   Stratmann, J A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

drug discrimination; morphine; opioids; rat; sex differences

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; BUPRENORPHINE; COCAINE; DELTA OPIATE RECEPTOR AGONIST; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISCRIMINATION; DRUG POTENCY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT; REINFORCEMENT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030426561     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Anthony JC and Helzer JE (1991) Syndromes of drug abuse and dependence. In: Psychiatric Disorders in America: The Epidemiologic Catchment Area Study (Eds LN Robins and DA Regier), pp.116-154. The Free Press, New York.
2. Baamonde AI, Hidalgo A and Andres-Trelles F (1989) Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology, 28, 967-970.
3. Beatty WW and Holzer GA (1978) Sex differences in stereotyped behavior in the rat. Pharmacology, Biochemistry and Behavior, 9, 777-783.
4. Becker JB, Robinson TE and Lorenz KA (1982) Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. European Journal of Pharmacology, 80, 65-72.
5. Blanchard BA and Glick SD (1995) Sex differences in mesolimbic dopamine responses to ethanol and relationship to ethanol intake in rats. In: Recent Developments in Alcoholism, Volume 12: Women and Alcoholism (Ed M Galanter), pp. 231-241. Plenum Press, New York.
6. Blizard DA, Lippman HR and Chen JJ (1975) Sex differences in open-field behavior in the rat: the inductive and activational role of gonadal hormones. Physiology and Behavior, 14, 610-608.
7. Camp DM and Robinson TE (1988) Susceptibility to sensitization. I. Sex differences in the enduring effects of chronic D-amphetamine treatment on locomotion, stereotyped behavior and brain monoamines. Behavioral Brain Research, 30, 55-68.
8. Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE and Yoburn BC (1992) Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacology, Biochemistry and Behavior, 42, 685-692.
9. Castner SA, Xiao L and Becker JB (1993) Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Research, 610, 127-134.
10. Chait LD (1994) Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology, 113, 381-387.
11. Chait LD, Uhlenhuth EH and Johanson C-E (1989) Individual differences in the discriminative stimulus effects of d-amphetamine in humans. Drug Development Research, 16, 451-460.
12. Colpaert FC (1995) Drug discrimination: no evidence for tolerance to opiates. Pharmacological Reviews, 47, 605-629.
13. Colpaert FC, Niemegeers CJE and Janssen PAJ (1975) The narcotic cue: evidence for the specificity of the stimulus properties of narcotic drugs. Archives of International Pharmacodynamics and Therapeutics, 218, 268-276.
14. Comer SD, McNutt RW, Chang K-J, DeCosta BR, Mosberg HI and Woods JH (1993) Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors. Journal of Pharmacology and Experimental Therapeutics, 267, 866-874.
15. Craft RM and Stratmann JA (1996) Discriminative stimulus properties of cocaine in female versus male rats. Drug and Alchohol Dependence, in press.
16. Craft RM, Henley SR, Haaseth RC, Hruby VJ and Porreca F (1995) Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. Journal of Pharmacology and Experimental Therapeutics, 275, 1535-1542.
17. De Vry J, Koek W and Slangen JL (1984) Effects of drug-induced differences in reinforcement frequency on discriminative stimulus properties of fentanyl. Psychopharmacology, 83, 257-261.
18. Dum JE and Herz A (1981) In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions. British Journal of Pharmacology, 74, 627-633.
19. Dykstra LA (1979) Effects of morphine, pentazocine and cyclazocine alone and in combination with naloxone on electric shock titration in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 211, 722-732.
20. Forgie ML and Stewart J (1994) Sex differences in the locomotor-activating effects of amphetamine: role of circulating testosterone in adulthood. Physiology and Behavior, 55, 639-644.
21. France CP, Jacobson AE and Woods JH (1984) Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine. Journal of Pharmacology and Experimental Therapeutics, 230, 652-657.
22. Gauvin DV and Young AM (1989) Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology, 98, 212-221.
23. Grant K and Johanson C (1988) Oral ethanol self-administration in free-feeding rhesus monkeys. Alcoholism: Clinical and Experimental Research, 12, 780-784.
24. Hammer RP (1990) μ-Opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Research, 515, 187-192.
25. Hayes AG, Sheehan MJ and Tyers MB (1987) Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to μ- and κ-opioid receptor agonists. British Journal of Pharmacology, 91, 823-832.
26. Heyser CJ, Rajachandran L, Spear NE and Spear LP (1994) Responsiveness to cocaine challenge in adult rats following prenatal exposure to cocaine. Psychopharmacology, 116, 45-55.
27. Jasinski DR and Henningfield JE (1989) Human abuse liability assessment by measurement of subjective and physiological effects. In: Testing for Abuse Liability of Drugs in Humans (Eds MW Fischman and NK Mello). NIDA Research Monograph 92, U.S. Government Printing Office: Washington, D.C.
28. Johnston LD, O'Malley PM and Bachman JG (1994a) National Survey Results on Drug Use From the Monitoring the Future Study, 1975-1993 (Vol. I), NIH Publication No. 94-3809, p. 55.
29. Johnston LD, O'Malley PM and Bachman JG (1994b) National Survey Results on Drug Use From the Monitoring the Future Study, 1975-1993 (Vol. II), NIH Publication No. 94-3810, p. 153.
30. Joyce EM and Iverson SD (1979) The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neuroscience Letters, 14, 207-212.
31. Juarez J, Guzman-Flores C, Ervin F and Palmour R (1993) Voluntary alcohol consumption in vervet monkeys: individual, sex and age differences. Pharmacology, Biochemistry and Behavior, 46, 985-988.
32. Kalivas PW and Duffy P (1987) Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. Journal of Pharmacology and Experimental Therapeutics, 241, 204-212.
33. Kelleher RT and Morse WH (1969) Determinants of the behavioral effects of drugs. In: Importance of Fundamental Principles in Drug Evaluation (Eds DH Tedeschi and RE Tedeschi), pp. 383-405. Raven Press, New York.
34. Kepler KL, Kest B, Kiefel JM, Cooper ML and Bodnar RJ (1989) Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacology, Biochemistry and Behavior, 34, 119-127.
35. Kepler KL, Standifer KM, Paul D, Kest B, Pasternak GW and Bodnar RJ (1991) Gender effects and central opioid analgesia. Pain, 45, 87-94.
36. Klitenick MA and Wirtshafter D (1995) Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area. Journal of Pharmacology and Experimental Therapeutics, 273, 327-336.
37. Koek W and Slangen JL (1982) The role of fentanyl training dose and of the alternative stimulus condition in drug generalization. Psychopharmacology, 76, 149-156.
38. 3H]U-69593: a highly selective ligand for the opioid κ receptor. European Journal of Pharmacology, 109, 281-284.
39. Magnan J, Paterson SJ, Tavani A and Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Archives of Pharmacology, 319, 197-205.
40. McMillan DE and Morse WH (1967) Some effects of morphine and morphine antagonists on schedule-controlled behavior. Journal of Pharmacology and Experimental Therapeutics, 157, 175-184.
41. O'Neal MF, Means LW, Porter JH, Rosrans JA and Mokler DJ (1988) Rats that acquire a THC discrimination more rapidly are more sensitive to THC and faster in reaching operant criteria. Pharmacology, Biochemistry and Behavior, 29, 67-71.
42. Negus SS and Dykstra LA (1988) κ Antagonist properties of buprenorphine in the shock titration procedure. European Journal of Pharmacology, 156, 77-86.
43. Negus SS, Picker MJ and Dykstra LA (1990) Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology, 102, 465-473.
44. Negus SS, Picker MJ and Dykstra LA (1991) Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 256, 149-158.
45. NIDA (1994) 1993 National Household Survey on Drug Abuse: Preliminary Estimates 1993, DHHS Advance Report No. 7. US Government Printing Office, Washington, D.C.
46. Paronis CA and Holtzman SG (1994) Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psychopharmacology, 114, 601-610.
47. Paule MG and Wenger GR (1986) Morphine discrimination in the pigeon using a color tracking procedure. Pharmacology, Biochemistry and Behavior, 24, 597-604.
48. Perkins KA, DiMarco A, Grobe JE, Scierka A and Stiller RL (1994) Nicotine discrimination in male and female smokers. Psychopharmacology, 116, 407-413.
49. Picker MJ, Doty P, Negus SS, Mattox SR and Dykstra LA (1990) Discriminative stimulus properties of U50,488 and morphine: Effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. Journal of Pharmacology and Experimental Therapeutics, 254, 13-22.
50. Picker MJ, Craft RM, Negus SS, Powell KR, Mattox SR, Jones SR, Hargrove BK and Dykstra LA (1992) Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats. Journal of Pharmacology and Experimental Therapeutics, 263, 668-681.
51. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D and Dykstra LA (1993) Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. Journal of Pharmacology and Experimental Therapeutics, 266, 756-767.
52. 5]enkephalin: a synergistic interaction. European Journal of Pharmacology, 179, 463-468.
53. Roberts DCS, Bennett SAL and Vickers GJ (1989) The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology, 98, 408-411.
54. Savageau MM and Beatty WW (1981) Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats. Pharmacology, Biochemistry and Behavior, 14, 17-21.
55. Schaeffer GJ and Holtzman SG (1977) Discriminative effects of morphine in the squirrel monkey. Journal of Pharmacology and Experimental Therapeutics, 201, 67-75.
56. Schecter MD (1983) Drug sensitivity of individual rats determines degree of drug discrimination. Pharmacology, Biochemistry and Behavior, 19, 1-4.
57. Shannon HE and Holtzman SG (1976) Evaluation of the discriminative effects of morphine in the rat. Journal of Pharmacology and Experimental Therapeutics, 198, 54-65.
58. Shannon HE and Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology, 61, 239-244.
59. Simerly RB, McCall LD and Watson SJ (1988) Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism. Journal of Comparative Neurology, 276, 442-159.
60. Su T-P (1985) Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity. Journal of Pharmacology and Experimental Therapeutics, 232, 144-148.
61. Vanacek SA and Young AM (1995) Pharmacological characterization of an operant discrimination among two doses of morphine and saline in pigeons. Behavioral Pharmacology, 6, 669-681.
62. van Haaren F (1994) The effects of acute and chronic cocaine administration on paced responding in intact and gonadectomized male and female Wistar rats. Pharmacology, Biochemistry and Behavior, 48, 265-273.
63. van Haaren F and Anderson KG (1994) Behavioral effects of acute and chronic cocaine administration in male and female rats: effects of fixed-ratio schedule parameters. Behavioural Pharmacology, 5, 607-614.
64. van Haaren F and Meyer ME (1991) Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacology, Biochemistry and Behavior, 39, 923-927.
65. Walker EA, Makhay MM, House JD and Young AM (1994) In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. Journal of Pharmacology and Experimental Therapeutics, 271, 959-968.
66. Young AM, Stephens KR, Hein DW and Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. Journal of Pharmacology and Experimental Therapeutics, 229, 118-126.
67. Young AM, Masaki MA and Geula C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. Journal of Pharmacology and Experimental Therapeutics, 261, 246-257.